Generic drugmaker Emcure Pharmaceuticals is gearing up for its Initial Public Offering (IPO), scheduled to launch on July 3, 2024. This move follows the approval from the Securities and Exchange Board of India (SEBI) on June 20, 2024. Preliminary Steps and SEBI Approval The preliminary filings by Emcure Pharmaceuticals were submitted to SEBI in December …


